Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target

- Islam, Saiful, Wang, Shudong, Bowden, Nikola, Martin, Jennifer, Head, Richard

Aminoguanidines: new leads for treatment of Giardia duodenalis infection

- Abraham, Rebecca J., Abraham, Sam, Stevens, Andrew J., Page, Stephen W., McCluskey, Adam, Trott, Darren J., O'Handley, Ryan M.

Contemporary anti-Ebola drug discovery approaches and platforms

- Schneider-Futschik, Elena K., Hoyer, Daniel, Khromykh, Alexander A., Baell, Jonathan B., Marsh, Glenn A., Baker, Mark A., Li, Jian, Velkov, Tony

In vivo experimental models of infection and disease

- Girkin, Jason, Maltby, Steven, Singanayagam, Aran, Bartlett, Nathan, Malia, Patrick

Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials

- Manton, Kerry J., Gauld, Cassandra S., White, Katherine M., Griffin, Paul M., Elliott, Suzanne L.

The bispidinone derivative 3,7-Bis-[2-(S)-amino-3-(1H-indol-3-yl)-propionyl]-1,5-diphenyl-3,7-diazabicyclo[3.3.1]nonan-9-one dihydrochloride induces an apoptosis-mediated cytotoxic effect on pancreatic cancer cells in vitro

- Predebon, Melanie J., Bond, Danielle R., Scarlett, Christopher J., Brzozowski, Joshua, Jankowski, Helen, Deane, Fiona, Tarleton, Mark, Shaw, Aron A., McCluskey, Adam, Bowyer, Michael C., Weidenhofer, Judith

A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours

- Dredge, Keith, Brennan, Todd V., Millward, Michael, Hammond, Edward, Lickliter, Jason D., Liwen, Lin, Bampton, Darryn, Handley, Paul, Lankesheer, Fleur, Morrish, Glynn, Yang, Yiping

Inhibiting the NusB-NusE protein-protein interaction - a novel target for antibiotic drug development

- Cossar, Peter

Bacterial transcription as a target for antibacterial drug development

- Ma, Cong, Yang, Xiao, Lewis, Peter J.

Efficacy of Indian polyvalent snake antivenoms against Sri Lankan snake venoms: lethality studies or clinically focussed in vitro studies

- Maduwage, Kalana, Silva, Anjana, O'Leary, Margaret A., Hodgson, Waynbe C., Isbister, Geoffrey K.

Norcantharidin suppresses colon cancer cell epithelial-mesenchymal transition by inhibiting the alpha v beta 6-ERK-ets1 signaling pathway

- Peng, Cheng, Li, Zequn, Lin, Pengfei, Agrez, Michael, Zhang, Zongli, Niu, Jun, Niu, Zhengchuan, Niu, Wei, Xu, Zongquan, Gao, Huijie, Niu, Weibo, Wang, JiaYong, He, Zhaobin, Gao, Chao